DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,264,569 | +2.9% | 263,058 | -0.5% | 4.52% | +6.9% |
| Q2 2023 | $63,426,104 | -5.3% | 264,275 | -0.6% | 4.23% | -10.8% |
| Q1 2023 | $67,004,417 | -6.3% | 265,848 | -1.3% | 4.75% | -8.5% |
| Q4 2022 | $71,494,931 | +2.7% | 269,365 | -0.0% | 5.18% | -4.8% |
| Q3 2022 | $69,588,000 | -1.5% | 269,417 | -3.3% | 5.44% | +1.7% |
| Q2 2022 | $70,646,000 | -14.2% | 278,660 | -0.8% | 5.35% | -0.5% |
| Q1 2022 | $82,370,000 | -11.9% | 280,811 | -1.2% | 5.38% | -2.0% |
| Q4 2021 | $93,473,000 | +5.8% | 284,104 | -2.1% | 5.49% | +1.4% |
| Q3 2021 | $88,334,000 | +12.5% | 290,153 | -0.8% | 5.42% | +9.3% |
| Q2 2021 | $78,528,000 | +14.9% | 292,623 | -3.6% | 4.96% | +8.9% |
| Q1 2021 | $68,350,000 | -0.2% | 303,670 | -1.5% | 4.55% | -7.0% |
| Q4 2020 | $68,463,000 | -1.1% | 308,198 | -4.2% | 4.89% | -13.9% |
| Q3 2020 | $69,247,000 | +15.2% | 321,584 | -5.4% | 5.68% | +6.7% |
| Q2 2020 | $60,134,000 | +21.7% | 340,068 | -4.7% | 5.32% | +3.0% |
| Q1 2020 | $49,405,000 | -10.4% | 356,943 | -0.7% | 5.17% | +11.2% |
| Q4 2019 | $55,161,000 | +6.0% | 359,403 | -0.3% | 4.64% | -0.9% |
| Q3 2019 | $52,056,000 | +0.3% | 360,423 | -0.8% | 4.69% | -0.1% |
| Q2 2019 | $51,924,000 | +7.9% | 363,306 | -0.3% | 4.69% | +1.9% |
| Q1 2019 | $48,125,000 | +27.4% | 364,526 | -0.5% | 4.60% | +9.3% |
| Q4 2018 | $37,762,000 | -4.8% | 366,196 | +0.3% | 4.21% | +13.3% |
| Q3 2018 | $39,655,000 | +8.7% | 364,945 | -1.3% | 3.72% | +0.5% |
| Q2 2018 | $36,482,000 | +0.9% | 369,701 | +0.1% | 3.70% | -0.6% |
| Q1 2018 | $36,164,000 | +4.9% | 369,355 | -0.6% | 3.72% | +2.6% |
| Q4 2017 | $34,491,000 | +6.6% | 371,588 | -1.5% | 3.63% | +2.4% |
| Q3 2017 | $32,364,000 | +2.6% | 377,285 | +0.9% | 3.54% | +0.8% |
| Q2 2017 | $31,551,000 | -2.7% | 373,870 | -1.4% | 3.51% | -6.7% |
| Q1 2017 | $32,432,000 | +5.5% | 379,183 | -4.0% | 3.77% | +14.3% |
| Q4 2016 | $30,735,000 | +0.3% | 394,853 | +1.1% | 3.30% | -3.7% |
| Q3 2016 | $30,630,000 | -22.1% | 390,733 | +0.3% | 3.42% | -24.3% |
| Q2 2016 | $39,336,000 | +6.5% | 389,466 | -0.0% | 4.52% | +4.0% |
| Q1 2016 | $36,946,000 | +0.7% | 389,482 | -1.4% | 4.35% | -2.8% |
| Q4 2015 | $36,700,000 | +2.7% | 395,132 | -5.8% | 4.47% | +0.8% |
| Q3 2015 | $35,728,000 | -1.2% | 419,292 | -0.8% | 4.44% | +5.8% |
| Q2 2015 | $36,159,000 | -1.7% | 422,467 | -2.5% | 4.19% | -2.2% |
| Q1 2015 | $36,782,000 | -0.7% | 433,242 | +0.3% | 4.29% | -4.5% |
| Q4 2014 | $37,039,000 | +12.2% | 432,142 | -0.5% | 4.49% | +5.4% |
| Q3 2014 | $33,009,000 | -7.1% | 434,442 | -3.7% | 4.26% | +1.3% |
| Q2 2014 | $35,519,000 | +5.0% | 451,151 | +0.0% | 4.21% | +1.3% |
| Q1 2014 | $33,825,000 | -2.7% | 451,001 | +0.1% | 4.15% | -4.2% |
| Q4 2013 | $34,775,000 | +11.1% | 450,451 | -0.2% | 4.33% | -0.2% |
| Q3 2013 | $31,302,000 | +9.1% | 451,553 | -0.4% | 4.34% | +0.9% |
| Q2 2013 | $28,690,000 | – | 453,237 | – | 4.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |